ketanserin has been researched along with Pulmonary Fibrosis in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the effect of ketanserin on hemopoietic progenitor cells (Lin(-)Sca-1(+)c-Kit(+)CD34- and Lin(-)Sca-1(+)c-Kit(+)CD34(+)), progenitor hemopoietic cells (Lin(-)Sca-1(+)c-kit(+)), and multipotent mesenchymal stromal cells (CD45(-)CD73(+)CD106(+)) in C57Bl/6 mice during pulmonary fibrosis." | 7.80 | Response of hemopoietic, progenitor, and multipotent mesenchymal stromal cells to administration of ketanserin during pulmonary fibrosis. ( Dygai, AM; Ermakova, NN; Goldberg, VE; Khmelevskaya, ES; Krupin, VA; Pershina, OV; Reikhart, DV; Reztsova, AM; Skurikhin, EG; Stepanova, IE, 2014) |
| "We studied the effect of ketanserin on hemopoietic progenitor cells (Lin(-)Sca-1(+)c-Kit(+)CD34- and Lin(-)Sca-1(+)c-Kit(+)CD34(+)), progenitor hemopoietic cells (Lin(-)Sca-1(+)c-kit(+)), and multipotent mesenchymal stromal cells (CD45(-)CD73(+)CD106(+)) in C57Bl/6 mice during pulmonary fibrosis." | 3.80 | Response of hemopoietic, progenitor, and multipotent mesenchymal stromal cells to administration of ketanserin during pulmonary fibrosis. ( Dygai, AM; Ermakova, NN; Goldberg, VE; Khmelevskaya, ES; Krupin, VA; Pershina, OV; Reikhart, DV; Reztsova, AM; Skurikhin, EG; Stepanova, IE, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dygai, AM | 1 |
| Skurikhin, EG | 1 |
| Pershina, OV | 1 |
| Stepanova, IE | 1 |
| Khmelevskaya, ES | 1 |
| Ermakova, NN | 1 |
| Reztsova, AM | 1 |
| Krupin, VA | 1 |
| Reikhart, DV | 1 |
| Goldberg, VE | 1 |
| Fabre, A | 1 |
| Marchal-Sommé, J | 1 |
| Marchand-Adam, S | 1 |
| Quesnel, C | 1 |
| Borie, R | 1 |
| Dehoux, M | 1 |
| Ruffié, C | 1 |
| Callebert, J | 1 |
| Launay, JM | 1 |
| Hénin, D | 1 |
| Soler, P | 1 |
| Crestani, B | 1 |
2 other studies available for ketanserin and Pulmonary Fibrosis
| Article | Year |
|---|---|
Response of hemopoietic, progenitor, and multipotent mesenchymal stromal cells to administration of ketanserin during pulmonary fibrosis.
Topics: Animals; Bone Marrow; Cell Differentiation; Cells, Cultured; Hematopoietic Stem Cells; Ketanserin; L | 2014 |
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Fibroblasts; Humans; Ketanserin; Lung; Male; Mice; | 2008 |